Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

PE Hub

VC-backed Cibus prices IPO

Xconomy

MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal

Xconomy

Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs

Robotics
$70,000,000 Venture capital (Series B)
PE Hub , FinSMEs

Akero Therapeutics locks in $70 mln Series B

Xconomy

Agbio Startup Cibus Files for an IPO to Support Gene-Editing R&D

PE Hub

Cibus files to go public

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$421,000,000 IPO
AVCJ

Innovent Biologics gains on debut after $421m IPO

$70,000,000 IPO
Xconomy

Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology

Earnings Funding Science
$200,000,000 IPO
PE Hub , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
PE Hub

China's Innovent prices HK IPO near top end, raises $421 million, say sources: Reuters

$80,000,000 Venture capital (Series D)
FinSMEs , Xconomy

TP Therapeutics Completes $80M Mezzanine Financing

Funding Health
PE Hub

China's Innovent Biologics looks to raise up to $422 million in HK IPO, say sources: Reuters

$125,000,000 Venture capital (Series C)
FinSMEs , PE Hub , MedCity News

Atreca Raises $125M in Series C Funding

Funding
$42,300,000 Venture capital (Series B)
FinSMEs , Xconomy , PE Hub , +1

Renovia Completes $42.3M in Series B and Debt Financing

Funding Health
$150,000,000 Venture capital (Series C)
FinSMEs

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
Xconomy

FDA Puts Mersana Cancer Study on Partial Hold After Patient Death

Health
$60,000,000 IPO
PE Hub

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
$70,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D

Funding
$65,000,000 Venture capital (Series A)
FinSMEs

Akero Therapeutics Closes $65M Series A Financing

Funding Health Science